Mannit

Mannitol, the active ingredient in Mannit, is an osmotic diuretic presented as an intravenous solution for intravenous use. It reduces intracranial pressure, promotes diuresis in acute renal failure, and can lower intra‑ocular pressure in emergency settings.

GNH USA supplies Mannit as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Mannit is an osmotic diuretic used in clinical situations where rapid fluid shift is required.

- Reduction of intracranial pressure: lowers elevated pressure in traumatic brain injury or neurosurgery patients. - Acute renal failure: increases urine output to aid renal clearance. - Intra‑ocular hypertension: rapidly decreases pressure in acute glaucoma or ocular emergencies.

Mannit may cause a range of adverse reactions, most of which are related to its osmotic activity and fluid shifts.

Common Side Effects: - Headache: mild to moderate discomfort. - Nausea or vomiting: gastrointestinal upset. - Thirst or dry mouth: due to osmotic draw. - Electrolyte imbalance: especially sodium and potassium shifts. - Dizziness or light‑headedness: from volume changes. - Transient hypotension: mild blood pressure drop.

Serious or Rare Side Effects: - Pulmonary edema: fluid accumulation in lungs. - Acute renal failure worsening: if renal perfusion is compromised. - Severe hyponatremia or hypernatremia: dangerous electrolyte disturbances. - Anaphylactic reaction: rare hypersensitivity. - Cardiac arrhythmia: due to electrolyte shifts. - Hemolysis: especially in patients with G6PD deficiency.

Mannit requires careful monitoring and specific safety measures before and during administration.

- Renal function assessment: evaluate baseline creatinine and urine output. - Electrolyte monitoring: check serum sodium, potassium, and osmolality regularly. - Cardiovascular status: monitor blood pressure and heart rhythm during infusion. - Fluid balance: track input and output to avoid overload. - Contraindications review: avoid in patients with severe pulmonary edema or active intracranial hemorrhage. - Store at ambient temperature: keep below 25°C, protect from moisture and direct sunlight, and retain in original packaging.

Mannit can interact with several drug classes, affecting fluid and electrolyte balance.

Major Interactions (Avoid): - Loop diuretics (e.g., furosemide): may cause profound electrolyte loss. - Nephrotoxic agents (e.g., aminoglycosides, amphotericin B): increase risk of renal injury. - Insulin or oral hypoglycemics: heightened risk of hypoglycemia due to altered plasma volume.

Moderate Interactions (Monitor Closely): - Antihypertensives (e.g., ACE inhibitors, ARBs): may potentiate blood pressure drops. - Lithium: risk of lithium toxicity from altered renal clearance. - Carbamazepine or other anticonvulsants: possible changes in serum drug levels.